Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Publisher: Karger

E-ISSN: 1421-9794|57|2|108-114

ISSN: 0009-3157

Source: Chemotherapy, Vol.57, Iss.2, 2011-03, pp. : 108-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content